In a bylined article, Litigation & Dispute Resolution partners Mark Mansour, Christopher Mikson, and associate Emily Strunk (all Washington DC) discuss a stem cell warning letter sent by the FDA signaling an increased enforcement trend.

Downloads –

Related Capabilities

Industries –